{"id":15518,"date":"2011-08-01T11:16:14","date_gmt":"2011-08-01T11:16:14","guid":{"rendered":"http:\/\/i-base.info\/htb\/?p=15518"},"modified":"2012-07-26T11:19:12","modified_gmt":"2012-07-26T11:19:12","slug":"18th-conference-on-retroviruses-and-opportunistic-infections-croi-27-february-3-march-2011-boston-2-2","status":"publish","type":"post","link":"https:\/\/i-base.info\/htb\/15518","title":{"rendered":"18th Conference on Retroviruses and Opportunistic Infections (CROI)  27 February-\u00963 March 2011, Boston"},"content":{"rendered":"<p><strong>Introduction<\/strong><\/p>\n<p>Our final reports from this important conference are:<\/p>\n<ul>\n<li><a title=\"Permanent link to Monitoring treatment in resource limited settings: results from PHPT-3 and Stratall ANRS12110\/ESTER trials\" href=\"https:\/\/i-base.info\/htb\/15521\" rel=\"bookmark\">Monitoring treatment in resource limited settings: results from PHPT-3 and Stratall ANRS12110\/ESTER trials<\/a><\/li>\n<\/ul>\n<ul>\n<li><a title=\"Permanent link to DART: high rates of viral suppression after five years and a single CD4 test with a threshold of 250 cells\/mm3 could reduce unnecessary switching\" href=\"https:\/\/i-base.info\/htb\/15523\" rel=\"bookmark\">DART: high rates of viral suppression after five years and a single CD4 test with a threshold of 250 cells\/mm3 could reduce unnecessary switching<\/a><\/li>\n<\/ul>\n<ul>\n<li><a title=\"Permanent link to Lopinavir\/r monotherapy used as second-line therapy in resource-limited settings\" href=\"https:\/\/i-base.info\/htb\/15525\" rel=\"bookmark\">Lopinavir\/r monotherapy used as second-line therapy in resource-limited settings<\/a><\/li>\n<\/ul>\n<ul>\n<li><a title=\"Permanent link to Treating children previously exposed to single dose nevirapine: update on IMPAACT P1060 and NEVEREST\" href=\"https:\/\/i-base.info\/htb\/15531\" rel=\"bookmark\">Treating children previously exposed to single dose nevirapine: update on IMPAACT P1060 and NEVEREST<\/a><\/li>\n<\/ul>\n<ul>\n<li><a title=\"Permanent link to Lopinavir\/ritonavir oral solution toxicity in neonates\" href=\"https:\/\/i-base.info\/htb\/15534\" rel=\"bookmark\">Lopinavir\/ritonavir oral solution toxicity in neonates<\/a><\/li>\n<\/ul>\n<ul>\n<li><a title=\"Permanent link to Paediatric antiretroviral pipeline: darunavir and raltegravir\" href=\"https:\/\/i-base.info\/htb\/15536\" rel=\"bookmark\">Paediatric antiretroviral pipeline: darunavir and raltegravir<\/a><\/li>\n<\/ul>\n<ul>\n<li><a title=\"Permanent link to Pharmacokinetics of different rifabutin dosing strategies with lopinavir\/ritonavir-based ART\" href=\"https:\/\/i-base.info\/htb\/15527\" rel=\"bookmark\">Pharmacokinetics of different rifabutin dosing strategies with lopinavir\/ritonavir-based ART<\/a><\/li>\n<\/ul>\n<ul>\n<li><a title=\"Permanent link to Initiation of ART during breastfeeding can induce multidrug resistance in infants\" href=\"https:\/\/i-base.info\/htb\/15529\" rel=\"bookmark\">Initiation of ART during breastfeeding can induce multidrug resistance in infants<\/a><\/li>\n<\/ul>\n<p>Unless mentioned otherwise, all references are to the Programme and Abstracts of the 18th Conference on Retroviruses and Opportunistic Infections, 28 February\u00962 March 2011, Boston.<\/p>\n<p><a href=\"http:\/\/www.retroconference.org\/AbstractSearch\/\">http:\/\/www.retroconference.org\/AbstractSearch\/<\/a><\/p>\n<p>Webcasts are available at the following link:<\/p>\n<p><a href=\"http:\/\/www.retroconference.org\/2011\/data\/files\/webcast_2011.htm\">http:\/\/www.retroconference.org\/2011\/data\/files\/webcast_2011.htm<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Introduction Our final reports from this important conference are: Monitoring treatment in resource limited settings: results from PHPT-3 and Stratall ANRS12110\/ESTER trials DART: high rates of viral suppression after five years and a single CD4 test with a threshold of &hellip;<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[4],"tags":[12,65],"class_list":["post-15518","post","type-post","status-publish","format-standard","hentry","category-conference-reports","tag-conference-index","tag-croi-2011"],"_links":{"self":[{"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/posts\/15518","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/comments?post=15518"}],"version-history":[{"count":0,"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/posts\/15518\/revisions"}],"wp:attachment":[{"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/media?parent=15518"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/categories?post=15518"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/i-base.info\/htb\/wp-json\/wp\/v2\/tags?post=15518"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}